Delaware Growth and Income Fund

Delaware Growth and Income Fund*

Key features

An investment approach which is backed by data and science, removing emotional biases inherent in stock picking

A diversified portfolio focused on high quality companies with strong and growing dividends

Aims to consistently deliver returns in excess of the benchmark through various market conditions

Daily pricing as of 02/03/2023

NAV
$14.05
NAV 1-day net change
-0.11
Max offer price
$14.05

Total net assets as of 12/31/2022

All share classes
$984.2 million

Overview

Fund information
Inception date 04/01/2013
Dividends paid (if any) Quarterly
Capital gains paid (if any) November or December
Fund identifiers
NASDAQ FGIPX
CUSIP 24611D862

Benchmark and peer group

Russell 1000® Value Index (view definition)

Morningstar Large Value Category (view definition)

Lipper Equity Income Funds Average (view definition)

Performance

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.

Total returns may reflect waivers and/or expense reimbursements by the manager and/or distributor for some or all of the periods shown. Performance would have been lower without such waivers and reimbursements.

Average annual total return as of month-end (01/31/2023)

Returns for less than one year are not annualized.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

Average annual total return as of quarter-end (12/31/2022)

Returns for less than one year are not annualized.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

Overall Morningstar RatingTM

Institutional Class shares - as of 12/31/2022

MorningstarMorningstarMorningstar
Rating No. of funds
Overall 3 1148
3 years 4 1148
5 years 3 1094
10 years 3 810
Morningstar category Morningstar Large Value Category

(View Morningstar disclosure)

The Morningstar rating is based on risk-adjusted returns.

Morningstar ranking - as of 12/31/2022
1 year 35 / 1229
3 years 347 / 1155
5 years 479 / 1099
10 years n/a
Morningstar category Morningstar Large Value Category

(View Morningstar disclosure)

The Morningstar ranking is based on historical total returns.

Expense ratio

Gross
0.82%
Net
0.77%

Net expense ratio reflects a contractual waiver of certain fees and/or expense reimbursements from January 28, 2022 through January 28, 2023. Please see the fee table in the Fund's prospectus for more information.

Calendar year total returns @ NAV

Year
Annual return
Year
Annual return
2022
3.34%
2021
21.86%
2020
0.17%
2019
25.48%
2018
-10.12%
2017
18.51%
2016
9.85%
2015
-3.10%
2014
7.72%

Portfolio

Portfolio characteristics as of 12/31/2022

Number of holdings
58
Market cap (median) Source: FactSet
$53.3 billion
Market cap (weighted average) Source: FactSet
$139.5 billion
Portfolio turnover (last fiscal year)
23%
Beta (relative to Russell 1000 Value Index) (view definition)
0.95
SEC 30-day yield with waiver (view definition)
2.07%
SEC 30-day yield without waiver (view definition)
2.02%
Annualized standard deviation, 3 years (view definition)
21.34

Portfolio composition as of 12/31/2022
Total may not equal 100% due to rounding.

Domestic equities
99.6%
Cash, cash equivalents and other assets
0.4%

Top 10 holdings as of 12/31/2022

Holdings are as of the date indicated and subject to change.

List may exclude cash and cash equivalents. Please see the Fund's complete list of holdings for more information.

Holdings based by issuer.

Holding
% of portfolio
Holding
% of portfolio
Exxon Mobil Corp.
6.15
Merck & Co. Inc.
4.49
Bristol-Myers Squibb Co.
4.02
Gilead Sciences Inc.
3.85
Cisco Systems Inc.-(PRE-MERGER)
3.62
Cigna Holding Co.
3.58
TJX Companies Inc.
3.57
Johnson & Johnson
3.47
Philip Morris International Inc.
3.42
Conocophillips
3.41

Total % Portfolio in Top 10 holdings - 39.58%

List of monthly holdingsList of quarterly holdings

Sector allocation as of 12/31/2022

List may exclude cash, cash equivalents, and exchange-traded funds (ETFs) that are used for cash management purposes. Please see the Fund’s complete list of holdings for more information.

Sector
Fund
Sector
Fund
Healthcare
24.3%
Financials
19.5%
Information technology
12.7%
Energy
12.3%
Consumer discretionary
10.6%
Communication services
8.2%
Industrials
6.2%
Consumer staples
5.9%

Distribution history - annual distributions (Institutional Class)1,2
Distributions ($ per share)

Year
Capital gains3
Net investment income
Year
Capital gains3
Net investment income
2023
0.000
0.000
2022
0.635
0.364
2021
1.346
0.381
2020
0.695
0.230
2019
6.935
0.467
2018
4.015
0.385
2017
0.942
0.397
2016
0.754
0.332
2015
0.934
0.269
2014
1.045
0.235
2013
0.684
0.150

1If a Fund makes a distribution from any source other than net income, it is required to provide shareholders with a notice disclosing the source of such distribution (each a "Notice"). The amounts and sources of distributions reported above and in each Notice are only estimates and are not provided for tax reporting purposes. Each Fund will send each shareholder a Form 1099 DIV for the calendar year that will provide definitive information on how to report the Fund's distributions for federal income tax purposes. The information in the table above will not be updated to reflect any subsequent recharacterization of dividends and distributions. Click here to see recent Notices pertaining to the Fund (if any).

2Information on return of capital distributions (if any) is only provided from June 1, 2014 onward.

3Includes both short- and long-term capital gains.

Management

Scot Thompson

Scot Thompson 

  • Managing Director, Co-Head of Systematic Investments, Portfolio Manager
  • Start date on the Fund: January 2021
  • Years of industry experience: 25
  • Read bio
Benjamin Leung

Benjamin Leung, CFA

  • Managing Director, Co-Head of Systematic Investments, Head of Research
  • Start date on the Fund: January 2021
  • Years of industry experience: 21
  • Read bio

Fees

Shareholder fees
Maximum sales charge (load) imposed on purchases as a percentage of offering price none
Maximum contingent deferred sales charge (load) as a percentage of original purchase price or redemption price, whichever is lower none
Annual fund operating expenses
Management fees 0.62%
Distribution and service (12b-1) fees none
Other expenses 0.19%
Total annual fund operating expenses 0.81%
Fee waivers and expense reimbursements1 (0.04%)
Total annual fund operating expenses after fee waivers and expense reimbursements 0.77%

Please see the prospectus and SAI for additional information.

1Net expense ratio reflects a contractual waiver of certain fees/and/or expense reimbursements from January 28, 2022 through January 28, 2023. Please see the fee table in the Fund's prospectus for more information.

Institutional Class shares are available only to certain investors. See the prospectus for more information.

1 The Fund’s investment manager, Delaware Management Company (Manager), has contractually agreed to waive all or a portion of its investment advisory fees and/or pay/reimburse expenses (excluding any acquired fund fees and expenses, taxes, interest, short sale dividend and interest expenses, brokerage fees, certain insurance costs, and nonroutine expenses or costs, including, but not limited to, those relating to reorganizations, litigation, conducting shareholder meetings, and liquidations) in order to prevent total annual fund operating expenses from exceeding 0.77% of the Fund’s average daily net assets from January 28, 2022 through January 28, 2023. These waivers and reimbursements may only be terminated by agreement of the Manager and the Fund.

Resources

* At a meeting on Nov. 18, 2020, Delaware Group® Equity Funds IV Board of Trustees ( the “Board”) approved the replacement of the Fund’s current portfolio managers with the Global Systematic Investment team of the Fund’s current sub-advisor, Macquarie Investment Management Global Limited (MIMGL). In connection with this determination, the Board approved certain changes to the Fund’s investment strategies. These portfolio management and strategy changes will be effective on or about January 29, 2021. The investment management changes may result in higher portfolio turnover in the near term, as the new portfolio management team purchases and sells securities to accommodate the investment changes. A higher portfolio turnover is likely to cause the Fund to realize capital gains and incur transaction costs. You should consult your financial advisor about the changes that will result from the investment strategy changes. Please see the supplement in the Fund’s prospectus dated Nov. 23, 2020 for more information.

Frank Russell Company (“Russell”) is the source and owner of the trademarks, service marks, and copyrights related to the Russell Indexes. Russell® is a trademark of Russell..

Carefully consider the Fund's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Fund's prospectus and it's summary prospectus, which may be obtained by visiting delawarefunds.com/literature or calling 877 693-3546. Investors should read the prospectus and the summary prospectus carefully before investing.

Carefully consider the Fund's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Fund's prospectus and it's summary prospectus, which may be obtained by visiting delawarefunds.com/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.

Investing involves risk, including the possible loss of principal.

REIT investments are subject to many of the risks associated with direct real estate ownership, including changes in economic conditions, credit risk, and interest rate fluctuations.

There is no guarantee that dividend-paying stocks will continue to pay dividends.

Natural or environmental disasters, such as earthquakes, fires, floods, hurricanes, tsunamis, and other severe weather-related phenomena generally, and widespread disease, including pandemics and epidemics, have been and can be highly disruptive to economies and markets, adversely impacting individual companies, sectors, industries, markets, currencies, interest and inflation rates, credit ratings, investor sentiment, and other factors affecting the value of the Fund’s investments. Given the increasing interdependence among global economies and markets, conditions in one country, market, or region are increasingly likely to adversely affect markets, issuers, and/or foreign exchange rates in other countries. These disruptions could prevent the Fund from executing advantageous investment decisions in a timely manner and could negatively impact the Fund’s ability to achieve its investment objective. Any such event(s) could have a significant adverse impact on the value and risk profile of the Fund.

All third-party marks cited are the property of their respective owners.

Not FDIC Insured • No Bank Guarantee • May Lose Value

You can check the background of your investment professional on FINRA's BrokerCheck.

Nothing presented should be construed as a recommendation to purchase or sell any security or follow any investment technique or strategy.

You can check the background of your investment professional on FINRA's BrokerCheck.